Abstract
Botulinum toxin has gained widespread acceptance as a treatment option for various spastic gastrointestinal disorders such as achalasia, gastroparesis, sphincter of Oddi dysfunction, chronic anal fissures, and pelvic floor dyssnergia, despite the lack of strong evidence supporting its use in many of these disorders. This review summarizes the trials investigating the use of BoNT since it was first utilized as a treatment in achalasia. BoNT has proven to be safe, but long-term efficacy in many disorders has not been observed, primarily due to is relatively short duration of action. BoNT may be most useful in confirming a diagnosis which can lead to a more definitive treatment modality. Furthermore, its safety profile allows it to be a useful alternative in patients who are at high risk for invasive procedures.
Similar content being viewed by others
References
Abbott RD, H Petrovitch, LR White, KH Masaki, CM Tanner, JD Curb, A Grandinetti, PL Blanchette, JS Popper and GW Ross (2001) Frequency of bowel movements and the future risk of Parkinson’s disease.Neurology 57(3), 456–462.
Albanese A, G Maria, AR Bentivoglio, G Brisinda, E Cassetta and P Tonali (1997) Severe constipation in Parkinson’s disease relieved by botulinum toxin.Mov. Disord. 12(5), 764–766.
Albanese A, G Brisinda, AR Bentivoglio and G Maria (2003) Treatment of outlet obstruction constipation in Parkinson’s disease with botulinum neurotoxin A.Am. J. Gastroenterol. 98(6), 1439–1440.
Albani G, ML Petroni, A Mauro, A Liuzzi, G Lezzi, B Verti, P Marzullo and L Cattani (2005) Safety and efficacy of therapy with botulinum toxin in obesity: a pilot study.J. Gastroenterol. 40(8), 833–835.
Alberty J, M Oelerich, K Ludwig, S Hartmann and W Stoll (2000) Efficacy of botulinum toxin A for treatment of upper esophageal sphincter dysfunction.Laryngoscope 110(7), 1151–1156.
Annese V, M Basciani, F Perri, G Lombardi, V Frusciante, P Simone, A Andriulli and G Vantrappen (1996) Controlled trial of botulinum toxin injection versus placebo and pneumatic dilation in achalasia.Gastroenterology 111(6), 1418–1424.
Annese V, G. Bassotti, G Coccia, V D’Onofrio, G Gatto, A Repici and A Andriulli (1999) Comparison of two different formulations of botulinum toxin A for the treatment of oesophageal achalasia. The Gismad Achalasia Study Group.Aliment. Pharmacol. Ther. 13(10), 1347–1350.
Annese V, G Bassotti, G Coccia, M Dinelli, V D’Onofrio, G Gatto, G Leandro, A Repici, PA Testoni and A Andriulli (2000) A multicentre randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia. GISMAD Achalasia Study Group.Gut 46(5), 597–600.
Argov S and O Levandovsky (2000) Open lateral sphincterotomy is still the best treatment for chronic anal fissure.Am. J. Surg. 179(3), 201–202.
Arroyo A, F Perez, P Serrano, F Candela, J Lacueva and R Calpena (2005a) Surgical versus chemical (botulinum toxin) sphincterotomy for chronic anal fissure: long-term results of a prospective randomized clinical and manometric study.Am. J. Surg. 189(4), 429–434.
Arroyo A, F Perez-Vicente, E Miranda, P Serrano, M Perez-Vazquez and R Calpena (2005b) [Manometric factors associated with recurrence in botulinum toxin treatment for chronic anal fissure.].Gastroenterol. Hepatol. 28(6), 311–314.
Bachmann G, M Streppel, B Krug and E Neuen-Jacob (2001) Cricopharyngeal muscle hypertrophy associated with florid myositis.Dysphagia 16(4), 244–248.
Bansal R, TT Nostrant, JM Scheiman, S Koshy, JL Barnett, GH Elta and WD Chey (2003) Intrasphincteric botulinum toxin versus pneumatic balloon dilation for treatment of primary acha-lasia.J. Clin. Gastroenterol. 36(3), 209–214.
Barnes PR, PR Hawley, DM Preston and JE Lennard-Jones (1985) Experience of posterior division of the puborectalis muscle in the management of chronic constipation.Br. J. Surg. 72(6), 475–477.
Bassotti G, F Chistolini, F Sietchiping-Nzepa, G de Roberto, A Morelli and G Chiarioni (2004) Biofeedback for pelvic floor dysfunction in constipation.Bmj 328(7436), 393–396.
Bonavina L, R Incarbone, L Antoniazzi, M Reitano and A Peracchia (1999) Previous endoscopic treatment does not affect complication rate and outcome of laparoscopic Heller myotomy and anterior fundoplication for oesophageal achalasia.Ital. J. Gastroenterol. Hepatol. 31(9), 827–830.
Bonavina L, R Incarbone, M Reitano, L Antoniazzi and A Peracchia (2000) Does previous endoscopic treatment affect the outcome of laparoscopic Heller myotomy?Ann. Chir. 125(1), 45–49.
Brant CQ, ES Siqueira and AP Ferrari Jr (1999) Botulinum toxin for oropharyngeal dysphagia: case report of flexible endoscope-guided injection.Dis. Esophagus 12(1), 68–73.
Brisinda G and G Maria (2000) Oral nifedipine reduces resting anal pressure and heals chronic anal fissure.Br. J. Surg. 87(2), 251.
Brisinda G, G Maria, AR Bentivoglio, E Cassetta, D Gui and A Albanese (1999) A comparison of injections of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure.N. Engl. J. Med. 341(2), 65–69.
Brisinda G, G Maria, G Sganga, AR Bentivoglio, A Albanese and M Castagneto (2002) Effectiveness of higher doses of botulinum toxin to induce healing in patients with chronic anal fissures.Surgery 131(2), 179–184.
Brisinda G, A Albanese, F Cadeddu, AR Bentivoglio, A Mabisombi, G Marniga and G Maria (2004) Botulinum neurotoxin to treat chronic anal fissure: results of a randomized “Botoxvs. Dysport” controlled trial.Aliment. Pharmacol. Ther. 19(6), 695–701.
Bromer MQ, F Friedenberg, LS Miller, RS Fisher, K Swartz and HP Parkman (2005) Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory gastroparesis.Gastrointest. Endosc. 61(7), 833–839.
Brown AC, JM Sumfestand JV Rozwadowski (1989) Histopathology of the internal anal sphincter in chronic anal fissure.Dis. Colon Rectum 32(8), 680–683.
Chiu MJ, YC Chang and TY Hsiao (2004) Prolonged effect of botulinum toxin injection in the treatment of cricopharyngeal dysphagia: case report and literature review.Dysphagia 19(1), 52–57.
Cook TA, MM Humphreys and NJ McMortensen (1999) Oral nifedipine reduces resting anal pressure and heals chronic anal fissure.Br. J. Surg. 86(10), 1269–1273.
Csendes A, G Smok, I Braghetto, C Ramirez, N Velasco and A Henriquez (1985) Gastroesophageal sphincter pressure and histological changes in distal esophagus in patients with achalasia of the esophagus.Dig. Dis. Sci. 30(10), 941–945.
Ezzeddine D, R Jit, N Katz, N Gopalswamy and MS Bhutani (2002) Pyloric injection of botulinum toxin for treatment of diabetic gastroparesis.Gastrointest. Endosc. 55(7), 920–923.
Garcia-Compean D, E Mendoza-Fuerte, JA Martinez, I Villarreal and H Maldonado (2005) Endoscopic injection of botulinum toxin in the gastric antrum for the treatment of obesity. Results of a pilot study.Gastroenterol. Clin. Biol. 29(8-9), 789–791.
Geenen JE, WJ Hogan, WJ Dodds, J Toouli and RP Venu (1989) The efficacy of endoscopic sphincterotomy after cholecystec-tomy in patients with sphincter-of-Oddi dysfunction.N. Engl. J. Med. 320(2), 82–87.
Giral A, K Memisoglu, Y Gultekin, N Imeryuz, C Kalayci, NB Ulusoy and N Tozun (2004) Botulinum toxin injection versus lateral internal sphincterotomy in the treatment of chronic anal fissure: a non-randomized controlled trial.BMC Gastroenterol. 4,7.
Gui D, A De Gaetano, PL Spada, A Viggiano, E Cassetta and A Albanese (2000) Botulinum toxin injected in the gastric wall reduces body weight and food intake in rats.Aliment. Pharmacol. Ther. 14(6), 829–834.
Gupta P and S S Rao (2002) Attenuation of isolated pyloric pressure waves in gastroparesis in response to botulinum toxin injection: a case report.Gastrointest. Endosc. 56(5), 770–772.
Haapaniemi JJ, EA Laurikainen, J Pulkkinen and RJ Marttila (2001) Botulinum toxin in the treatment of cricopharyngeal dysphagia.Dysphagia 16(3), 171–175.
Hallan RI, NS Williams, J Melling, DJ Waldron, NR Womack and JF Morrison (1988) Treatment of anismus in intractable constipation with botulinum A toxin.Lancet 2(8613), 714–717.
Halum SL, SG Butler, JA Koufman and GN Postma (2005) Treatment of globus by upper esophageal sphincter injection with botulinum A toxin.Ear Nose Throat J. 84(2), 74.
Hananel N and PH Gordon (1997) Lateral internal sphincterotomy for fissure-in-ano--revisited.Dis. Colon Rectum 40(5), 597–602.
Hansen MB (2003) The enteric nervous system I: organisation and classification.Pharmacol. Toxicol. 92(3), 105–113.
Henry MA and RG Prado (1998) [Use of botulin toxin in the treatment of diffuse esophageal spasm. A case report].Arq. Gastroenterol. 35(4), 274–277.
Horgan S, K Hudda, T Eubanks, J McAllister and CA Pellegrini (1999) Does botulinum toxin injection make esophagomyotomy a more difficult operation?Surg. Endosc. 13(6), 576–579.
Iswariah H, J Stephens, N Rieger, D Rodda and P Hewett (2005) Randomized prospective controlled trial of lateral internal sphincterotomy versus injection of botulinum toxin for the treatment of idiopathic fissure in ano.ANZ J. Surg. 75(7), 553–555.
James AN, JP Ryan, and HP Parkman (2003) Inhibitory effects of botulinum toxin on pyloric and antral smooth muscle.Am. J. Physiol. Gastrointest. Liver Physiol. 285(2), G291-G297.
Joo JS, F Agachan, B Wolff, JJ Nogueras and SD Wexner (1996) Initial North American experience with botulinum toxin type A for treatment of anismus.Dis. Colon Rectum 39(10), 1107–1111.
Kelly JH (2000) Management of upper esophageal sphincter disorders: indications and complications of myotomy.Am. J. Med. 108 Suppl. 4a, 43S-46S.
Kennedy ML, S Sowter, H Nguyen and DZ Lubowski (1999) Glyceryl trinitrate ointment for the treatment of chronic anal fissure: results of a placebo-controlled trial and long-term follow-up.Dis. Colon Rectum 42(8), 1000–1006.
Lacy BE, EN Zayat, MD Crowell and MM Schuster (2002) Botulinum toxin for the treatment of gastroparesis: a preliminary report.Am. J. Gastroenterol. 97(6), 1548–1552.
Lacy BE, MD Crowell, A Schettler-Duncan, C Mathis and PJ Pasricha (2004) The treatment of diabetic gastroparesis with botulinum toxin injection of the pylorus.Diabetes Care 27(10), 2341–2347.
Lewis TH, ML Corman, ED Prager and WG Robertson (1988) Long-term results of open and closed sphincterotomy for anal fissure.Dis. Colon Rectum 31(5), 368–371.
Liu LW, M Tarnopolsky and D Armstrong (2004) Injection of botulinum toxin A to the upper esophageal sphincter for oropha-ryngeal dysphagia in two patients with inclusion body myositis.Can. J. Gastroenterol. 18(6), 397–399.
Lysy J, Y Israelit-Yatzkan, M Sestiery-Ittah, S Weksler-Zangen, D Keret and E Goldin (2001) Topical nitrates potentiate the effect of botulinum toxin in the treatment of patients with refractory anal fissure.Gut 48(2), 221–224.
Madalinski MH, J Slawek, B Zbytek, W Duzynski, Z Adrich, K Jagiello and A Kryszewski (2001) Topical nitrates and the higher doses of botulinum toxin for chronic anal fissure.Hepatogastroenterology 48(40), 977–979.
Madalinski M, Z Adrich and A Kryszewski (2002) [Nitric oxide donors and their potentiating effects after botulinum toxin application for treatment of chronic anal fissure].Pol. Arch. Med. Wewn. 107(1), 69–74.
Maria G, E Cassetta, D Gui, G Brisinda, AR Bentivoglio and A Albanese (1998) A comparison of botulinum toxin and saline for the treatment of chronic anal fissure.N. Engl. J. Med. 338(4), 217–220.
Maria G, G Brisinda, AR Bentivoglio, E Cassetta, D Gui and A Albanese (2000) Influence of botulinum toxin site of injections on healing rate in patients with chronic anal fissure.Am. J. Surg. 179(1), 46–50.
Maria G, G Brisinda, AR Bentivoglio, A Albanese, G Sganga and Castagneto M (2001) Anterior rectocele due to obstructed defecation relieved by botulinum toxin.Surgery 129(5), 524–529.
Massoud BW, V Mehrdad, T Baharak and Z Alireza (2005) Botulinum toxin injection versus internal anal sphincterotomy for the treatment of chronic anal fissure. Ann.Saudi Med. 25(2), 140–142.
Mentes BB, O Irkorucu, M Akin, S Leventoglu and E Tatlicioglu (2003) Comparison of botulinum toxin injection and lateral internal sphincterotomy for the treatment of chronic anal fissure.Dis. Colon Rectum 46(2), 232–237.
Mikaeli J, A Fazel, G Montazeri, M Yaghoobi and R Malekzadeh (2001) Randomized controlled trial comparing botulinum toxin injection to pneumatic dilatation for the treatment of achalasia.Aliment. Pharmacol. Ther. 15(9), 1389–1396.
Miller LS, SV Pullela, HP Parkman, TD Schiano, MJ Cassidy, S Cohen and RS Fisher (2002a) Treatment of chest pain in patients with noncardiac, nonreflux, nonachalasia spastic esophageal motor disorders using botulinum toxin injection into the gastro-esophageal junction.Am. J. Gastroenterol. 97(7), 1640–1646.
Miller LS, GA Szych, SB Kantor, MQ Bromer, LC Knight, AH Maurer, RS Fisher and HP Parkman (2002b) Treatment of idio-pathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle.Am. J. Gastroenterol. 97, 1653–1660.
Moerman M, Y Callier, C Dick and H Vermeersch (2002) Botulinum toxin for dysphagia due to cricopharyngeal dysfunction.Eur. Arch. Otorhinolaryngol. 259(1), 1–3.
Muehldorfer SM, EG Hahn and C Ell (1997) Botulinum toxin injection as a diagnostic tool for verification of sphincter of Oddi dysfunction causing recurrent pancreatitis.Endoscopy 29(2), 120–124.
Muehldorfer SM, TH Schneider, J Hochberger, P Martus, EG Hahn and Ell C (1999) Esophageal achalasia: intrasphincteric injection of botulinum toxin A versus balloon dilation.Endoscopy 31(7), 517–521.
Murry T, T Wasserman, RL Carrau and B Castillo (2005) Injection of botulinum toxin A for the treatment of dysfunction of the upper esophageal sphincter.Am. J. Otolaryngol. 26(3), 157–162.
Neubrand M, C Scheurlen, M Schepke and T Sauerbruch (2002) Long-term results and prognostic factors in the treatment of achalasia with botulinum toxin.Endoscopy 34(7), 519–523.
Olgart C, LE Gustafsson and NP Wiklund (2000) Evidence for nonvesicular nitric oxide release evoked by nerve activation.Eur. J. Neurosci. 12(4), 1303–1309.
Parameswaran MS and AM Soliman (2002) Endoscopic botulinum toxin injection for cricopharyngeal dysphagia. Ann.Otol. Rhinol. Laryngol. 111(10), 871–874.
Pasricha PJ, WJ Ravich and AN Kalloo (1993) Botulinum toxin for achalasia.Lancet 341(8839), 244–245.
Pasricha PJ, EP Miskovsky and AN Kalloo (1994a) Intrasphincteric injection of botulinum toxin for suspected sphincter of Oddi dysfunction.Gut 35(9), 1319–1321.
Pasricha PJ, WJ Ravich, TR Hendrix, S Sostre, BS Jones and AN Kalloo N (1994b) Treatment of achalasia with intrasphincteric injection of botulinum toxin. A pilot trial. Ann.Intern. Med. 121(8), 590–591.
Pasricha PJ, WJ Ravich, TR Hendrix, S Sostre, B Jones and AN Kalloo, A. N (1995) Intrasphincteric botulinum toxin for the treatment of achalasia.N. Engl. J. Med. 332(12), 774–778.
Pasricha PJ, R Rai, WJ Ravich, TR Hendrix and AN Kalloo (1996) Botulinum toxin for achalasia: long-term outcome and predictors of response.Gastroenterology 110(5), 1410–1415.
Ravich WJ (2001) Botulinum toxin for UES dysfunction: therapy or poison?Dysphagia 16(3), 168–170.
Restivo DA, A Palmeri and R Marchese-Ragona (2002) Botulinum toxin for cricopharyngeal dysfunction in Parkinson’s disease.N. Engl. J. Med. 346(15), 1174–1175.
Reynolds JC and HP Parkman (1989) Achalasia.Gastroenterol. Clin. North Am. 18(2), 223–255.
Rollnik JD, PN Meier, MP Manns and M Goke (2003) Antral injections of botulinum a toxin for the treatment of obesity.Ann. Intern. Med. 138(4), 359–360.
Ron Y, Y Avni, A Lukovetski, J Wardi, D Geva, S Birkenfeld and Z Halpern (2001) Botulinum toxin type-A in therapy of patients with anismus.Dis. Colon Rectum 44(12), 1821–1826.
Schneider I, WF Thumfart, C Pototschnig and HE Eckel (1994) Treatment of dysfunction of the cricopharyngeal muscle with botulinum A toxin: introduction of a new, noninvasive method.Ann. Otol. Rhinol. Laryngol. 103(1), 31–35.
Schouten WR, JW Briel, JJ Auwerda and MO Boerma (1996) Anal fissure: new concepts in pathogenesis and treatment.Scand. J. Gastroenterol. Suppl.218, 78–81.
Shafik A and O El-Sibai (1998) Botulinum toxin in the treatment of nonrelaxing puborectalis syndrome.Dig. Surg. 15(4), 347–351.
Shaw GY and JP Searl (2001) Botulinum toxin treatment for cricopharyngeal dysfunction.Dysphagia 16(3), 161–167.
Siproudhis L, V Sebille, F Pigot, P Hemery, F Juguet and E Bellissant (2003) Lack of effficacy of botulinum toxin in chronic anal fissure.Aliment. Pharmacol. Ther. 18(5), 515–524.
Storr M, HD Allescher, T Rosch, P Born, N Weigert and M Classen (2001) Treatment of symptomatic diffuse esophageal spasm by endoscopic injections of botulinum toxin: a prospective study with long-term follow-up.Gastrointest. Endosc. 54(6), 754–759.
Storr M, R Linke, M Nicolaus, B Goke and J Schirra (2005) [Injection of botulinum toxin for diffuse esophageal spasm].Dtsch. Med. Wochenschr. 130(6), 266–269.
Thornton MJ, ML Kennedy and DW King (2005) Prospective manometric assessment of botulinum toxin and its correlation with healing of chronic anal fissure.Dis. Colon Rectum 48(7), 1424–1431.
Vaezi MF, JE Richter, CM Wilcox, PL Schroeder, S Birgisson, RL Slaughter, RE Koehler and ME Baker (1999) Botulinum toxin versus pneumatic dilatation in the treatment of achalasia: a randomised trial.Gut 44(2), 231–239.
Vogel JD (1999) A comparison of botulinum toxin and nitroglyc-erin ointment for chronic anal fissure.N. Engl. J. Med. 341(22), 1701.
Watanabe C, T Katakura, H Seino, Y Ota and S Kinai (1975) [A method of multidle body-section repersentation using x-ray television. Study on fluoroscopic tomography. I. (author’s transl)].Nippon Igaku Hoshasen Gakkai Zasshi 35(6), 383–393.
Wehrmann T, H Seifert, M Seipp, B Lembcke and WF Caspary (1998) Endoscopic injection of botulinum toxin for biliary sphincter of Oddi dysfunction.Endoscopy 30(8), 702–707.
Wehrmann T, T Schmitt and H Seifert (1999) Endoscopic botulinum toxin injection into the minor papilla for treatment of idio-pathic recurrent pancreatitis in patients with pancreas divisum.Gastrointest. Endosc. 50(4), 545–548.
Wehrmann T, TH Schmitt, A Arndt, B Lembcke, WF Caspary and Seifert, H (2000) Endoscopic injection of botulinum toxin in patients with recurrent acute pancreatitis due to pancreatic sphincter of Oddi dysfunction.Aliment. Pharmacol. Ther. 14(11), 1469–1477.
Yokoyama T, M Asai, M Kumada, S Usui and T Kobayasi (2003) [Botulinum toxin injection into the cricopharyngeal muscle for dysphagia: report of 2 successful cases].Nippon Jibiinkoka Gakkai Kaiho 106(7), 754–757.
Zaninotto G, V Annese, M Costantini, A Del Genio, M Costantino, M Epifani, G Gatto, V D’Onofrio, L Benini, S Contini, D Molena, G Battaglia, B Tardio, A Andriulli and E Ancona (2004a) Randomized controlled trial of botulinum toxin versus laparoscopic heller myotomy for esophageal achalasia.Ann. Surg. 239(3), 364–370.
Zaninotto G, R Marchese Ragona, C Briani, M Costantini, C Rizzetto, G Portale, L Zanetti, S Masiero, M Costantino, L Nicoletti, A Polidoro, G Feltrin, C Angelini, E Ancona, D Guidolin and AR Parenti (2004b) The role of botulinum toxin injection and upper esophageal sphincter myotomy in treating oropharyngeal dysphagia.J. Gastrointest. Surg. 8(8), 997–1006.
Zaninotto G, V Vergadoro, V Annese, M Costantini, M Costantino, D Molena, C Rizzetto, M Epifani, A Ruol, L Nicoletti and E Ancona (2004c) Botulinum toxin injection versus laparoscopic myotomy for the treatment of esophageal achalasia: economic analysis of a randomized trial.Surg. Endosc. 18(4), 691–695.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vittal, H., Pasricha, P.J. Botulinum toxin for gastrointestinal disorders: Therapy and mechanisms. neurotox res 9, 149–159 (2006). https://doi.org/10.1007/BF03033934
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03033934